drugset / Trial / NCT03685773

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

NCT03685773

Non-randomizedCrossoverSingle-blindBasic science

Summary

It is believed that important brain centers send signals through the vagus nerve to the liver to suppress the amount of glucose (sugar) that gets produced. People who have received liver transplants have had their vagus nerve cut during transplantation, and many of these individuals have diabetes at one year post-transplant. The goals of this study are: to see whether metabolic control centers in the brain can still be activated normally with the medication diazoxide in patients who have had a liver transplant, and to understand whether disrupting the vagus nerve would result in excess glucose being produced by the liver (ie. a potential mechanism for why these patients develop diabetes).

Timeline

Start
2019-04-21
Primary completion
2023-04-21
Completion
2023-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazoxide Unknown 7 mg/kg
Subject Niacin Small molecule